Regulus Therapeutics Stock (NASDAQ: RGLS) stock price, news, charts, stock research, profile.
You can purchase shares of Regulus Therapeutics (NASDAQ:RGLS) through any online brokerage.
Other companies in Regulus Therapeutics’s space includes: Skye Bioscience (NASDAQ:SKYE), Anixa Biosciences (NASDAQ:ANIX), Citius Oncology (NASDAQ:CTOR), Adicet Bio (NASDAQ:ACET) and Agenus (NASDAQ:AGEN).
Regulus Therapeutics has a consensus price target of $10.33.
The stock price for Regulus Therapeutics (NASDAQ: RGLS) is $1.58 last updated October 1, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Regulus Therapeutics.
Regulus Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Regulus Therapeutics.
Regulus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.